Assignee
HANMI SCIENCE CO LTD
KR·24 granted patents·9 pending applications·58 citations·filing 2011–2021
Top patents by PatentIndex Score
33 records- 0192US9522946B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2015·Granted Dec 20, 2016·11 cites·5 claims
- 0290US9981017B2Insulin conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2016·Granted May 29, 2018·4 cites·21 claims
- 0390US8859767B2Method for preparing 1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)-prop-2-en-1-one hydrochloride and intermediates used thereinHANMI SCIENCE CO LTD·Filed 2012·Granted Oct 14, 2014·8 cites·18 claims
- 0488US9765131B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2016·Granted Sep 19, 2017·5 cites·7 claims
- 0586US9750820B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2014·Granted Sep 5, 2017·4 cites·4 claims
- 0685US10071171B2Polypeptide complex comprising non-peptidyl polymer having three functional endsHANMI SCIENCE CO LTD·Filed 2015·Granted Sep 11, 2018·5 cites·22 claims
- 0782US10744187B2Insulin conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2018·Granted Aug 18, 2020·1 cites·18 claims
- 0881US9597378B2Blood coagulation factor VII and VIIa derivatives, conjugates and complexes comprising the same, and use thereofHANMI SCIENCE CO LTD·Filed 2012·Granted Mar 21, 2017·3 cites·27 claims
- 0981US9345719B2Fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2014·Granted May 24, 2016·4 cites·31 claims
- 1081US8940908B2Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in sameHANMI SCIENCE CO LTD·Filed 2014·Granted Jan 27, 2015·4 cites·5 claims
- 1180US10363320B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofHANMI SCIENCE CO LTD·Filed 2017·Granted Jul 30, 2019·1 cites·20 claims
- 1277US10071166B2Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2013·Granted Sep 11, 2018·1 cites·16 claims
- 1377US9504757B2Site-specific GLP-2 conjugate using an immunoglobulin fragmentHANMI SCIENCE CO LTD·Filed 2012·Granted Nov 29, 2016·4 cites·16 claims
- 1476US11058776B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2019·Granted Jul 13, 2021·0 cites·5 claims
- 1575US11872283B2Conjugate comprising oxyntomodulin and an immunoglobulin fragment, and use thereofHANMI SCIENCE CO LTD·Filed 2019·Granted Jan 16, 2024·0 cites·20 claims
- 1673US11168109B2Process for preparation of physiologically active polypeptide complexHANMI SCIENCE CO LTD·Filed 2013·Granted Nov 9, 2021·1 cites·15 claims
- 1772US11434271B2Method for preparing physiologically active polypeptide complexHANMI SCIENCE CO LTD·Filed 2012·Granted Sep 6, 2022·1 cites·9 claims
- 1870US2018326083A1Protein complex using an immunoglobulin fragment and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 1969US10272159B2IgG Fc fragment for a drug carrier and method for the preparation thereofHANMI SCIENCE CO LTD·Filed 2014·Granted Apr 30, 2019·0 cites·4 claims
- 2069USRE46511EFused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2011·Granted Aug 15, 2017·1 cites·54 claims
- 2168US11040110B2Polypeptide complex comprising non-peptidyl polymer having three functional endsHANMI SCIENCE CO LTD·Filed 2018·Granted Jun 22, 2021·0 cites·26 claims
- 2263US10442848B2Oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the sameHANMI SCIENCE CO LTD·Filed 2017·Granted Oct 15, 2019·0 cites·7 claims
- 2361US8586752B1Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing sameHANMI SCIENCE CO LTD·Filed 2013·Granted Nov 19, 2013·0 cites·7 claims
- 2460US2022064145A1Synthesis of poziotinib derivativeHANMI SCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2555US2018344866A1Liquid formulation of highly concentrated long-acting human growth hormone conjugateHANMI SCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 2652US10064951B2Liquid formulation of highly concentrated long-acting human growth hormone conjugateHANMI SCIENCE CO LTD·Filed 2013·Granted Sep 4, 2018·0 cites·18 claims
- 2752US2016229868A1Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activityHANMI SCIENCE CO LTD·Filed 2016·Application pending·0 cites
- 2851US2019083579A1Composition for treating diabetes comprising long-acting insulin conjugate and long-acting insulinotropic peptide conjugateHANMI SCIENCE CO LTD·Filed 2018·Application pending·0 cites
- 2947US9394560B2Method of culturing E. coli cells for high densityHANMI SCIENCE CO LTD·Filed 2013·Granted Jul 19, 2016·0 cites·17 claims
- 3043US2014357843A1Immunoglobulin fc variantsHANMI SCIENCE CO LTD·Filed 2012·Application pending·0 cites
- 3141US2015056223A1Pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver diseaseHANMI SCIENCE CO LTD·Filed 2013·Application pending·0 cites
- 3238US2013022684A1Oral pharmaceutical composition comprising fenofibric acid and an alkalifying agentHANMI SCIENCE CO LTD·Filed 2011·Application pending·0 cites
- 3337US2013028974A1Pharmaceutical formulation in the form of bilayered tablets comprising hmg-coa reductase inhibitor and irbesartanHANMI SCIENCE CO LTD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when HANMI SCIENCE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →